J. Scott Wolchko

2018

In 2018, J. Scott Wolchko earned a total compensation of $3.5M as President, Chief Executive Officer and Director at Fate Therapeutics, a 171% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$258,000
Option Awards$2,756,998
Salary$516,000
Total$3,530,998

Wolchko received $2.8M in option awards, accounting for 78% of the total pay in 2018.

Wolchko also received $258K in non-equity incentive plan and $516K in salary.

Rankings

In 2018, J. Scott Wolchko's compensation ranked 3,217th out of 14,244 executives tracked by ExecPay. In other words, Wolchko earned more than 77.4% of executives.

ClassificationRankingPercentile
All
3,217
out of 14,244
77th
Division
Manufacturing
1,195
out of 5,759
79th
Major group
Chemicals And Allied Products
414
out of 2,122
81st
Industry group
Drugs
342
out of 1,811
81st
Industry
Biological Products, Except Diagnostic Substances
74
out of 339
78th
Source: SEC filing on March 22, 2019.

Wolchko's colleagues

We found three more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2018.

2018

Bahram Valamehr

Fate Therapeutics

Chief Development Officer

2018

Cindy Tahl

Fate Therapeutics

General Counsel

2018

Daniel Shoemaker

Fate Therapeutics

Chief Scientific Officer

News

In-depth

You may also like